POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C2 Genetic Test
Are you concerned about muscular dystrophy-dystroglycanopathy limb-girdle type C2? DNA Labs UAE offers the POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C2 Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to the POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle) Type C2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle) Type C2.
Test Details
The POMT2 gene is associated with a type of muscular dystrophy called limb-girdle muscular dystrophy-dystroglycanopathy, type C2 (LGMD-C2). This genetic disorder affects the muscles, causing progressive muscle weakness and wasting, particularly in the muscles of the shoulders, upper arms, and hips.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic mutations that may be causing a particular disorder or condition. In the case of LGMD-C2, NGS genetic testing can be used to detect mutations in the POMT2 gene. This can help in confirming a diagnosis, identifying carriers of the condition, and providing genetic counseling for affected individuals and their families.
It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.
Test Name | POMT2 Gene Muscular dystrophy-dystroglycanopathy limb-girdle type C2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for POMT2 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C2 |
Test Details |
The POMT2 gene is associated with a type of muscular dystrophy called limb-girdle muscular dystrophy-dystroglycanopathy, type C2 (LGMD-C2). This genetic disorder affects the muscles, causing progressive muscle weakness and wasting, particularly in the muscles of the shoulders, upper arms, and hips. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic mutations that may be causing a particular disorder or condition. In the case of LGMD-C2, NGS genetic testing can be used to detect mutations in the POMT2 gene. This can help in confirming a diagnosis, identifying carriers of the condition, and providing genetic counseling for affected individuals and their families. It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support. |